Expression of RPL37A in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL37A is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3809.53

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3568.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	9360.7
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	9136.7
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	7876.4
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	6442.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	5662.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	5589.1
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	5512.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	5407.6
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	5404.5
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	5365.9
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	5363.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	5347.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	5184.0
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	5175.3
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	5131.6
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	5064.4
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	5033.0
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	4998.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	4725.8
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	4661.2
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	4627.7
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	4540.1
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	4538.5
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	4537.5
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4475.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	4418.8
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	4416.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	4370.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	4364.4
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	4358.2
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	4309.1
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	4293.9
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	4291.1
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	4201.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	4154.7
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	4139.1
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	4123.2
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	4084.0
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	4074.2
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	3993.1
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	3900.1
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3888.6
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	3880.4
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3877.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	3840.5
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	3809.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	3804.9
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3799.0
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3796.3
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	3746.0
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	3685.1
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	3626.2
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	3625.7
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	3621.8
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	3587.6
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	3581.2
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3561.0
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	3555.8
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	3542.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	3528.8
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	3518.1
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	3492.3
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	3490.6
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3486.5
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	3485.1
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	3431.9
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3418.2
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	3401.0
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	3380.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3375.9
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3335.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3281.2
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	3269.1
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	3254.0
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3237.3
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3235.5
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	3212.8
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	3165.8
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	3114.6
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	3110.4
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	3097.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3085.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	3048.7
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	3040.0
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3013.2
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	3009.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2997.8
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2992.9
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	2991.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2979.2
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	2962.5
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2941.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2934.7
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	2909.5
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2906.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	2905.7
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	2895.0
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2887.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2872.1
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	2848.8
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2842.9
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2832.3
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	2801.0
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2791.1
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2750.3
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2750.0
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2708.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2666.0
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	2660.8
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	2660.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	2647.6
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	2639.9
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	2635.7
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	2620.3
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2561.3
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2533.0
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	2520.9
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2517.4
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2517.3
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2503.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	2495.7
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	2484.2
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	2483.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2461.5
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	2456.7
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2434.0
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2418.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2391.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2367.0
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2328.4
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2326.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	2303.7
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	2300.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2262.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	2255.2
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2253.6
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2117.9
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2095.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1981.2
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1412.6
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1382.3
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL37A is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 282.91

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

360.5

Number of samples

Samples

Sample	Description	pTPM
AK043	N, NA, stage:NA, alive, 660 days	783.9
AK066	N, NA, stage:NA, alive, 960 days	738.8
AK142	N, NA, stage:NA, alive, 90 days	675.0
AK183	N, NA, stage:NA, alive, 360 days	525.9
AK041	N, NA, stage:NA, alive, 810 days	513.2
AK185	N, NA, stage:NA, alive, 330 days	511.8
AK139	N, NA, stage:NA, dead, 270 days	506.3
AK049	N, NA, stage:NA, dead, 180 days	504.2
AK002	N, NA, stage:NA, dead, 570 days	500.4
AK236	N, NA, stage:NA, dead, 360 days	495.9
AK124	N, NA, stage:NA, alive, 1920 days	468.5
AK231	N, NA, stage:NA, dead, 240 days	454.5
AK133	N, NA, stage:NA, dead, 360 days	451.3
AK055	N, NA, stage:NA, dead, 240 days	449.9
AK072	N, NA, stage:NA, dead, 150 days	444.2
AK165	N, NA, stage:NA, alive, 360 days	444.2
AK213	N, NA, stage:NA, alive, 2010 days	414.8
AK199	N, NA, stage:NA, alive, 1860 days	405.5
AK205	N, NA, stage:NA, dead, 120 days	405.3
AK178	N, NA, stage:NA, dead, 240 days	400.3
AK051	N, NA, stage:NA, dead, 360 days	388.8
AK103	N, NA, stage:NA, alive, 1320 days	386.4
AK134	N, NA, stage:NA, dead, 360 days	386.0
AK015	N, NA, stage:NA, alive, 720 days	366.2
AK173	N, NA, stage:NA, dead, 180 days	358.9
AK076	N, NA, stage:NA, alive, 660 days	356.2
AK195	N, NA, stage:NA, dead, 390 days	344.4
AK216	N, NA, stage:NA, dead, 360 days	341.8
AK071	N, NA, stage:NA, dead, 540 days	334.9
AK149	N, NA, stage:NA, dead, 420 days	330.5
AK074	N, NA, stage:NA, alive, 300 days	328.3
AK188	N, NA, stage:NA, alive, 420 days	327.3
AK085	N, NA, stage:NA, alive, 660 days	322.3
AK156	N, NA, stage:NA, dead, 330 days	322.2
AK098	N, NA, stage:NA, dead, 660 days	319.1
AK158	N, NA, stage:NA, dead, 360 days	314.2
AK102	N, NA, stage:NA, alive, 1740 days	288.5
AK117	N, NA, stage:NA, dead, 210 days	277.3
AK003	N, NA, stage:NA, dead, 600 days	269.3
AK218	N, NA, stage:NA, dead, 180 days	269.3
AK030	N, NA, stage:NA, dead, 120 days	261.3
AK100	N, NA, stage:NA, alive, 960 days	261.1
AK053	N, NA, stage:NA, dead, 300 days	256.5
AK123	N, NA, stage:NA, dead, 180 days	253.5
AK088	N, NA, stage:NA, dead, 360 days	248.7
AK227	N, NA, stage:NA, alive, 300 days	248.2
AK153	N, NA, stage:NA, dead, 240 days	244.9
AK167	N, NA, stage:NA, dead, 180 days	244.7
AK091	N, NA, stage:NA, dead, 210 days	244.5
AK081	N, NA, stage:NA, dead, 180 days	239.8
AK089	N, NA, stage:NA, dead, 330 days	239.1
AK079	N, NA, stage:NA, dead, 210 days	235.6
AK068	N, NA, stage:NA, alive, 360 days	232.0
AK099	N, NA, stage:NA, dead, 420 days	227.2
AK035	N, NA, stage:NA, dead, 210 days	226.0
AK226	N, NA, stage:NA, dead, 360 days	184.0
AK005	N, NA, stage:NA, dead, 240 days	179.0
AK006	N, NA, stage:NA, dead, 360 days	159.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0127480003	Tumor	0.7
CPT0182580003	Tumor	0.6
CPT0190360004	Tumor	0.6
CPT0225760003	Tumor	0.6
CPT0218330004	Tumor	0.6
CPT0093510003	Tumor	0.6
CPT0217000004	Tumor	0.5
CPT0206560003	Tumor	0.5
CPT0218690004	Tumor	0.5
CPT0206230003	Tumor	0.5
CPT0168830003	Tumor	0.5
CPT0206000004	Tumor	0.5
CPT0205450004	Tumor	0.4
CPT0171580008	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0087570003	Tumor	0.4
CPT0093590003	Tumor	0.4
CPT0189750004	Tumor	0.4
CPT0218830004	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0217430008	Tumor	0.3
CPT0168080003	Tumor	0.3
CPT0225730003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0168480003	Tumor	0.3
CPT0093450003	Tumor	0.3
CPT0078580003	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0205670004	Tumor	0.2
CPT0224540004	Tumor	0.2
CPT0162020003	Tumor	0.2
CPT0167860004	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0125510003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0175060003	Tumor	0.2
CPT0168380003	Tumor	0.2
CPT0208980003	Tumor	0.2
CPT0206880003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0217100003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0093550003	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0224390004	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0162100003	Tumor	0.1
CPT0204340003	Normal	0.1
CPT0205780003	Tumor	0.1
CPT0161730003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0168270003	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0204380003	Normal	0.0
CPT0182500003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0092440003	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0204400003	Normal	0.0
CPT0207090003	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0209440003	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0087950003	Tumor	-0.1
CPT0219080004	Tumor	-0.1
CPT0204350003	Normal	-0.1
CPT0189570004	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0206450003	Tumor	-0.1
CPT0196850003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0206780003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0182550003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0186100003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0189460003	Tumor	-0.2
CPT0217190003	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0199770003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0162140003	Tumor	-0.3
CPT0204390003	Normal	-0.3
CPT0218770003	Tumor	-0.3
CPT0064890003	Tumor	-0.3
CPT0204410003	Normal	-0.3
CPT0201710003	Tumor	-0.3
CPT0204420003	Normal	-0.3
CPT0206110003	Tumor	-0.3
CPT0204330003	Normal	-0.3
CPT0104220003	Tumor	-0.3
CPT0204370003	Normal	-0.4
CPT0071100003	Tumor	-0.4
CPT0190240004	Tumor	-0.4
CPT0224330003	Tumor	-0.5
CPT0189250003	Tumor	-0.5
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA065327
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade